Skip to main content
. Author manuscript; available in PMC: 2024 Jan 17.
Published in final edited form as: Lancet Gastroenterol Hepatol. 2023 Mar 16;8(6):511–522. doi: 10.1016/S2468-1253(23)00068-7

Figure 2: Improvement in liver fibrosis and no worsening of NASH (A) and resolution of NASH (B) at 48 weeks.

Figure 2:

p-values are two-sided and taken from a Cochran–Mantel–Haenszel test stratified by baseline diabetes status. Patients with missing outcomes were imputed as non-responders. NASH=non-alcoholic steatohepatitis. OR=odds ratio.